Belumosudil for treating chronic graft-versus-host disease after 2 or more systemic treatments in people 12 years and over

Supporting evidence

• Evaluation report

• Final draft guidance committee papers (PDF 2.2 MB)

  Published:

  07 February 2024

• Draft guidance consultation committee papers (PDF 10.06 MB)

  Published:

  07 February 2024